pancreatic tumor
We also report that the COX inhibitors sulindac, indomethacin and NS-398 inhibit cell growth in both COX-2-positive (BxPC-3) and COX-2-negative (PaCa-2) pancreatic tumor cell lines.
We also report that the COX inhibitors sulindac, indomethacin and NS-398 inhibit cell growth in both <span class="gene" id="10657949-9-101-106">COX-2</span>-positive (<span class="gene" id="10657949-9-117-123">BxPC-3</span>) and <span class="gene" id="10657949-9-129-134">COX-2</span>-negative (PaCa-2) <span class="disease" id="10657949-9-153-169">pancreatic tumor</span> cell lines.